Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program. // The Breast. – URL: https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all
Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program. The Breast. https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all
“Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.” The Breast.
@article{article67635,
title = {Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program},
journal = {The Breast},
url = {https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all}
}
ABSTRACT Objectives The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP),...